Evermay Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.49K Hold
250
﹤0.01% 466
2025
Q4
$12.7K Hold
250
﹤0.01% 427
2025
Q3
$13.9K Hold
250
﹤0.01% 420
2025
Q2
$17.3K Hold
250
﹤0.01% 397
2025
Q1
$17.6K Hold
250
﹤0.01% 399
2024
Q4
$21.5K Hold
250
﹤0.01% 378
2024
Q3
$29.8K Hold
250
﹤0.01% 372
2024
Q2
$35.7K Hold
250
0.01% 368
2024
Q1
$32.3K Hold
250
﹤0.01% 386
2023
Q4
$25.9K Hold
250
﹤0.01% 379
2023
Q3
$22.7K Hold
250
﹤0.01% 370
2023
Q2
$20.2K Hold
250
﹤0.01% 378
2023
Q1
$20K Hold
250
﹤0.01% 367
2022
Q4
$16.9K Hold
250
﹤0.01% 377
2022
Q3
$12K Hold
250
﹤0.01% 382
2022
Q2
$14K Hold
250
﹤0.01% 367
2022
Q1
$14K Hold
250
﹤0.01% 387
2021
Q4
$14K Hold
250
﹤0.01% 381
2021
Q3
$12K Sell
250
-6,220
-96% -$301K ﹤0.01% 372
2021
Q2
$271K Hold
6,470
0.05% 152
2021
Q1
$218K Hold
6,470
0.04% 164
2020
Q4
$226K Hold
6,470
0.05% 161
2020
Q3
$225K Hold
6,470
0.06% 147
2020
Q2
$212K Buy
+6,470
New +$206K 0.06% 147

Other funds holding NVO

Evermay Wealth Management's NVO Position: Q1 2026 in Review

Evermay Wealth Management held its Novo Nordisk (NVO) position steady in Q1 2026 at 250 shares worth $9.49K. The position accounts for ﹤0.01% of the portfolio, ranked #466.

Evermay Wealth Management first reported a position in NVO in Q2 2020 and has held it in 24 quarters since. The position peaked at $271K in Q2 2021. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Evermay Wealth Management held 250 shares of Novo Nordisk worth $9.49K as of Q1 2026.
  • Evermay Wealth Management left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up ﹤0.01% of Evermay Wealth Management's portfolio in Q1 2026, its #466 holding.
  • Evermay Wealth Management first reported a position in Novo Nordisk in Q2 2020 and has held it in 24 quarters since.
  • Evermay Wealth Management's Novo Nordisk position peaked at $271K in Q2 2021.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Evermay Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.